The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
02/25/2013
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Document Type:
Grants Notice
Funding Opportunity Number:
RFA-EB-13-002
Opportunity Category:
Discretionary
Posted Date:
Feb 25, 2013
Creation Date:
Feb 25, 2013
Original Closing Date for Applications:
Jan 07, 2014
Current Closing Date for Applications:
Jan 07, 2014
Archive Date:
Feb 07, 2014
Funding Instrument Type:
Grant
Category of Funding Activity:
Health
Category Explanation:
Expected Number of Awards:
Estimated Total Program Funding:
Award Ceiling:
Award Floor:
CFDA Number(s):
93.286
--
Discovery and Applied Research for Technological Innovations to Improve Human Health
93.307
--
Minority Health and Health Disparities Research
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Small businesses
Additional Information on Eligibility:
Agency Name
National Institutes of Health
Description
This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop and translate medical technologies aimed at reducing disparities in healthcare access and health outcomes. Appropriate medical technologies should be effective, affordable, culturally acceptable, and deliverable to those who need them. Responsive grant applications must involve a formal collaboration with a healthcare provider or other healthcare organization serving one or more health disparity populations during Phase I and Phase II.
